Novabay Pharmac released FY2024 Semi-Annual earnings on August 13 After-Market (EST), actual revenue USD 0, actual EPS USD -27.844

institutes_icon
PortAI
08-14 07:00
1 sources

Brief Summary

NovaBay Pharma reported its fiscal 2024 semi-annual results on August 13 (EST), disclosing $0 in revenue, a net loss of approximately $5.18 million, and an EPS of -27.844 USD.

Impact of The News

Financial Briefing Overview

Event Track
© 2026 Longbridge｜Disclaimer